Rafael Holdings Inc (RFL) FinancialsRFLRafael Holdings Inc

Rafael Holdings Inc (RFL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Healthcare, accounting for 59.2% of total sales, equivalent to $125.00K. Another important revenue stream is Real Estate. Understanding this composition is critical for investors evaluating how RFL navigates market cycles within the Pharmaceuticals industry.

Evaluating the bottom line, Rafael Holdings Inc maintains a gross margin of 68.72%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -3837.99%, while the net margin is -1618.99%. These profitability ratios, combined with a Return on Equity (ROE) of -41.74%, provide a clear picture of how effectively RFL converts its operational activities into shareholder value.

In the context of the broader market, RFL competes directly with industry leaders such as AXR and BEEP. With a market capitalization of $133.12M, it holds a leading position in the sector. When comparing efficiency, RFL's gross margin of 68.72% stands against AXR's 40.02% and BEEP's 45.94%. Such benchmarking helps identify whether Rafael Holdings Inc is trading at a premium or discount relative to its financial performance.

Rafael Holdings has shown fluctuating revenue with a significant drop of 50% year-over-year in Q3 2026, leading to a net loss of $4.23 million. However, gross margins have improved, reaching 68.72% in Q3 2026, indicating potential for better profitability in the future.